The latest attempt focuses on liraglutide, an older, once-daily injectable product in Novo Nordisk's GLP-1 agonist franchise sold as Victoza and Xultophy for diabetes and Saxenda for obesity.

Data Sources: PubMed was searched (to December 5, 2011) using the terms exenatide, liraglutide, albiglutide, and lixisenatide. The search was limited to studies published in English and conducted ...

Originally, liraglutide and semaglutide are produced at an industrial scale using genetically modified organisms. Developing a robust and scalable commercial GMP process to manufacture them ...

The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

Participants who took liraglutide for 40 weeks showed improvements in some lung function measures, like the ability to forcefully exhale air and transfer gas from the air into their bloodstream. While ...

Novo Nordisk A/S trimmed its forecasts as sales of the drugmaker’s blockbuster obesity and diabetes medicines struggle with competition in the US. Revenue will likely rise by as much as 21% and ...

Chris Mars, a Northfield artist and musician, recently released his new monograph, “7:42 P.M.,” along with his new album, “The Average Album.” ...